Company’s 36-month beta value is 1.56.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy”, 0 as “overweight”, 0 as “hold”, and 0 as “sell”.
The public float for LTRN is 8.16M, and currently, short sellers hold a 3.38% ratio of that floaft. The average trading volume of LTRN on July 08, 2025 was 58.10K shares.
LTRN stock’s latest price update
Lantern Pharma Inc (NASDAQ: LTRN)’s stock price has gone rise by 13.81% in comparison to its previous close of $3.15, however, the company has experienced a 13.45% increase in its stock price over the last five trading days. businesswire.com reported 2025-06-16 that DALLAS–(BUSINESS WIRE)–Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company developing targeted cancer therapies using its proprietary RADR® AI platform, today announces remarkable clinical observations for a patient in Lantern’s Phase 2 HARMONIC™ clinical trial. A 70-year-old never-smoker with advanced non-small cell lung cancer (NSCLC) has achieved a durable complete response in their target cancer lesions following treatment with LP-300 in combination with standard-o.
LTRN’s Market Performance
LTRN’s stock has risen by 13.45% in the past week, with a monthly rise of 4.52% and a quarterly rise of 19.90%. The volatility ratio for the week is 5.20% while the volatility levels for the last 30 days are 5.57% for Lantern Pharma Inc The simple moving average for the past 20 days is 11.50% for LTRN’s stock, with a -1.62% simple moving average for the past 200 days.
Analysts’ Opinion of LTRN
Many brokerage firms have already submitted their reports for LTRN stocks, with H.C. Wainwright repeating the rating for LTRN by listing it as a “Buy”. The predicted price for LTRN in the upcoming period, according to H.C. Wainwright is $32 based on the research report published on October 07, 2021 of the previous year 2021.
LTRN Trading at 5.36% from the 50-Day Moving Average
After a stumble in the market that brought LTRN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -41.40% of loss for the given period.
Volatility was left at 5.57%, however, over the last 30 days, the volatility rate increased by 5.20%, as shares surge +11.16% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.95% upper at present.
During the last 5 trading sessions, LTRN rose by +16.79%, which changed the moving average for the period of 200-days by -3.14% in comparison to the 20-day moving average, which settled at $3.22. In addition, Lantern Pharma Inc saw -16.43% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LTRN starting from Fletcher Aaron G.L., who sold 40,000 shares at the price of $3.09 back on Jun 13 ’25. After this action, Fletcher Aaron G.L. now owns 49,957 shares of Lantern Pharma Inc, valued at $123,600 using the latest closing price.
Kreis Leslie W., the 10% Owner of Lantern Pharma Inc, sale 40,000 shares at $3.09 during a trade that took place back on Jun 13 ’25, which means that Kreis Leslie W. is holding 49,957 shares at $123,600 based on the most recent closing price.
Stock Fundamentals for LTRN
The total capital return value is set at -1.26%. Equity return is now at value -75.66%, with -65.35% for asset returns.
Based on Lantern Pharma Inc (LTRN), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -98.09.
Currently, EBITDA for the company is -20.59 million with net debt to EBITDA at 0.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.86.
Conclusion
In a nutshell, Lantern Pharma Inc (LTRN) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
